論文掲載のお知らせ

September 17, 2019

 

Clinical Pharmacology & Therapeutics 最新号に、弊社のCSOである藤谷幹浩の論文が掲載されました。

 

長鎖ポリリン酸塩は、難治性潰瘍性大腸炎患者を高率に改善・粘膜治癒へと導く薬剤候補であることが示されています。

 

PMID: 31513280

DOI: 10.1002/cpt.1628

 

Title:

"Long‐chain polyphosphate is a potential agent for inducing mucosal healing of the colon in ulcerative colitis"

 

Abstract:

The goal of ulcerative colitis (UC) treatment has recently been shown to be “mucosal healing”, as no drug directly induces mucosal healing. Probiotics possess sufficient safety, but their efficacy in the treatment of UC remains controversial because of the influence of the intestinal conditions. It is believed that the identification of bioactive molecules produced by probiotics and their application will help to solve this issue. We therefore identified a probiotic‐derived long‐chain polyphosphate as a molecule enhancing the intestinal barrier function. This study demonstrated that long‐chain polyphosphate exhibited anti‐inflammatory effects in a human macrophage and IL‐10 KO transfusion mouse model. The first‐in‐human trial showed that 7 of the 10 enrolled acquired clinical remission, 4 of whom achieved endoscopic remission despite a history of treatment with anti‐TNF‐α agents. No adverse reactions were observed. Long‐chain polyphosphate might be useful for the treatment of refractory UC, even in patients with failure or intolerance to anti‐TNF‐α therapy.

 

 

Share on Facebook
Share on Twitter
Please reload

特集記事

論文掲載のお知らせ

September 17, 2019

1/3
Please reload

最新記事

September 17, 2019